Bio-Path Holdings, Inc. (BPTH) — 10-Q Filings
All 10-Q filings from Bio-Path Holdings, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Bio-Path's Cash Dries Up Amid Soaring R&D Costs, Raising Going Concern Doubts
— Aug 14, 2025 Risk: high
BIO-PATH HOLDINGS, INC. reported a significant increase in net loss for the three and six months ended June 30, 2025, primarily driven by increased research and -
Bio-Path Holdings Q1 2025: Net Loss of $1.7M
— May 15, 2025 Risk: medium
Bio-Path Holdings, Inc. filed its quarterly report for the period ending March 31, 2025. The company reported total assets of $7.06 million and total liabilitie -
Bio-Path Holdings Files Q3 2024 10-Q
— Nov 14, 2024 Risk: medium
Bio-Path Holdings, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results and provided updates on its business ope -
Bio-Path Holdings Q2 2024: Net Loss, Equity Offerings Detailed
— Aug 14, 2024 Risk: high
Bio-Path Holdings, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported total assets of $1.16 million and total liabilities of $398,000 -
Bio-Path Holdings Files 10-Q for Period Ending March 31, 2024
— May 14, 2024 Risk: medium
BIO-PATH HOLDINGS, INC. (BPTH) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Bio-Path Holdings, Inc. reported its Q1 2024 financial results on M
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX